Ardent Health, Inc. Common Stock (ARDT)
Healthcare › Services-General Medical & Surgical Hospitals, NEC
Price History
Feb 9, 2026 — Jul 9, 2026Investment Snapshot
- Trading 32% below Graham Number ($13.00) — significant margin of safety
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 18.2% — good return on equity
- Revenue growing at 6% annually
Ardent Health, Inc. Common Stock (ARDT) is a Healthcare company operating in Services-General Medical & Surgical Hospitals, NEC, listed on the NYSE , with a market capitalisation of $1.3 billion . Key value metrics: P/E ratio 9.7, P/B ratio 1.09, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 3 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Ardent Health, Inc. Common Stock — Fundamental Analysis Summary
Ardent Health, Inc. Common Stock (ARDT) is trading 32% below its Graham Number of $13.00 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 9.7x.
On financial health, ARDT shows a moderate Piotroski F-Score of 5/9, and solid return on equity of 18.2% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.97.
StockPik's composite Value Score for ARDT is 80/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ARDT shows revenue growing at 6% year-over-year, with earnings declining at 35%.